Staphylococcus aureus nasal decolonization in joint replacement surgery reduces infection

Clinical Orthopaedics and Related Research

Volumn 466, Issue 6, 2008, Pages 1349-1355

  Hacek, Donna M ^a,b   Robb, William J ^c,d   Paule, Suzanne M ^a   Kudrna, James C ^c,d   Stamos, Van Paul ^c,d   Peterson, Lance R ^a,d  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^b EVANSTON HOSPITAL   (United States)

^c ILLINOIS BONE AND JOINT INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; CHLORHEXIDINE GLUCONATE; PSEUDOMONIC ACID; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; BACTERIAL COLONIZATION; BACTERIUM DETECTION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INFECTION CONTROL; KNEE ARTHROPLASTY; MAJOR CLINICAL STUDY; MALE; NOSE SMEAR; OUTCOME ASSESSMENT; POSTOPERATIVE INFECTION; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; TOTAL HIP PROSTHESIS; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY; ARTICLE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; ECONOMICS; HETEROZYGOTE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; NOSE CAVITY; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT; CARRIER STATE; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUPIROCIN; NASAL CAVITY; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGICAL WOUND INFECTION;

EID: 44949248342     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-008-0210-y     Document Type: Conference Paper

References (18)

1. Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:1047-1053.
2. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am. 2005;87:1746-1751.
3. Cimochowski GE, Harostock MD, Brown B, Bernardi M, Alonzo N, Coyle K. Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg. 2001;71:1572-1579.
4. Horan TC, Gaynes RP. Surveillance of nosocomial infections. In: Mayhall GC, ed. Hospital Epidemiology and Infection Control. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2004:1659-1702.
5. Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol. 2005;26:916-922.
6. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM, Bogaers-Hofman D, de Baere GA, Stuurman A, van Belkum A, Kluytmans JA. Surgical site infections in orthopedic surgery: The effect of mupirocin nasal ointment in a double-blind, randomized, placebo controlled study. Clin Infec Dis. 2002;35:353-358.
7. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D, de Baere G, Kluytmans J. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical site infections in orthopedic surgery. Infect Control Hosp Epidemiol. 2000; 21:319-323.
8. Kaye KS, Engemann JJ, Mozaffari E, Carmeli Y. Reference group choice and antibiotic resistance outcomes. Emerg Infect Dis. 2004;10:1125-1128.
9. Kluytmans JA, Mouton JW, VandenBergh MF, Manders MJ, Maat AP, Wagenvoort JH, Michel MF, Verbrugh HA. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol. 1996;17:780-785.
10. Kluytmans JA, Wertheim HF. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005;33:3-8.
11. Kourbatova EV, Halvosa JS, King MD, Ray SM, White N, Blumberg HM. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA 300 clone as a cause of health care-associated infections among patients with prosthetic joint infections. Am J Infect Control. 2005;33:385-391.
12. Nicholson MR, Huesman LA. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control. 2006;34:44-48.
13. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Jacobson C, Smulders M, Gemmen E, Bharmal M. Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals. Infect Control Hosp Epidemiol. 2008;29:16-24.
14. Paule SM, Pasquariello AC, Hacek DM, Fisher AG, Thomson RB Jr, Kaul KL, Peterson LR. Direct detection of Staphylococcus aureus from adult and neonate nasal swab specimens using real-time polymerase chain reaction. J Molec Diag. 2004;6:191-196.
15. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA. Mupirocin and the risk of Staphylococcus aureus study team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871-1877.
16. Peterson LR, Hacek DM, Robicsek A. Case Study: A MRSA intervention at Evanston Northwestern Healthcare. Joint Comm J Qual Patient Safety. 2007;33:732-738.
17. VandenBergh MF, Kluytmans JA, van Hout BA, Maat AP, Seerden RJ, McDonnel J, Verbrugh HA. Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol. 1996;17:786-792.
18. Wilcox MH, Hall J, Pike H, Templeton PA, Fawley WN, Parnell P, Verity P. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect. 2003;54:196-201.